Artiva Biotherapeutics (ARTV)'s 30-day implied volatility (IV30) was 63.3% at the close on November 6, 2026, down from 71.4% the day before, against a 52-week range of 60.8% to 107.1%. Its 20-day historical volatility was 78.5%.
Data as of November 6, 2026.